StudyFinder

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

Search all categories
593 Study Matches

PSCI 21-038 Phase Ib Study of Brigatinib Plus Bevacizumab in Patients with ALK-rearranged Non-Small Cell Lung Cancer (NSCLC)

Clinical trial on the treatment of persons who are diagnosed with Lung Cancer.

Participants in this study will undergo screening tests and procedures to determine whether you are eligible to participate with the research study. If you meet the requirements to participate with the study, you be given Brigatinib by mouth each day for 7 days. If you do not experience any intolerable side effects while taking Brigatinib, you will receive an increased dose starting on Day 8 and take Brigatinib continuously each day thereafter. Bevacizumab will be given intravenously (IV) on Day 8 in combination with Brigatinib. The first 28 days of treatment is called Cycle 1. Starting Cycle 2 and thereafter, one cycle will consist of 21 days. Bevacizumab will be given on Day 1 every 21 days starting Cycle 2. Participation is expected to last until your disease worsens or you decide you no longer want to participate in the study. There will be a follow-up visit within 30 days of treatment discontinuation. The study team will check in with you every three months after this final visit to see how you are doing. If you decide to take part, this is what will happen: Since we are looking for the highest dose of the study drug that can be administered safely without severe or unmanageable side effects in participants that have Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLS), not everyone who participates in this research study will receive the same dose of the study drug. The dose you get will depend on the number of participants who have been enrolled in the study before you and how well they have tolerated their doses. If you take part in this research study, you will be given a drug diary. You will be asked to document information in the drug diary about the study drug you are being asked to take. If you take part in this research, study you will be given a study calendar. Information about what to expect during and between study visits will be included in the study calendar.

Yes
 

Takefumi Komiya
PSCI-CTO@pennstatehealth.psu.edu 717-531-5471
Medicine: Hematology and Medical Oncology (HERSHEY)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT04227028
STUDY00018451
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
lung cancer

Exclusion Criteria:
other cancer in the last 3 years
major surgery in the last 30 days
heart attack or stroke in the last 6 months
Cancer
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Insulitis, Inflammation, Dietary intake and Omega-3 Biostatus of Youth with Partial Remission of Type 1 Diabetes

Only 50% of patients with type 1 diabetes (T1D) recover insulin secretion function after 3 months of initial diagnosis, and this phase is called partial remission (PR) of T1D, also called "Honeymoon phase". During this PR phase of T1D, patients recover the ability to secrete more than 50% of their insulin secretion function. This phase of PR typically lasts no longer than 6 or up to12 months, and has been frequently defined as requiring exogenous insulin below 0.5 units per kilogram per day, and hemoglobin A1C is typically below 7.5%. Most recently the use of a coefficient called IDAA1C ≤ 9 has became more accepted as the methodology to determine the development of partial clinical remission of T1D (honeymoon phase). Prior data published by the SEARCH study (national epidemiological study) showed that youth with prolonged honeymoon phase had higher intake of omega -3 fatty acids, vitamin D intake and leucine intake than those youth without prolonged honeymoon phase of T1D. Currently, there are not approved medications to prolong this phase of partial remission of type 1 diabetes, however inducing PR in youth with T1D could potentially decrease the risk of multi-organ damage caused by chronic severe hyperglycemia associated to the chronic hyperglycemia related to T1D. We aim to perform a case- multiple control study between youth with prolonged partial remission phase of T1D after one year of diagnosis, and compare these youths with multiple controls matched by age, gender, race, and puberty stage to study the potential protective factors associated to the development of prolonged partial remission of T1D.

Participants will be approached at their routine Pediatric diabetes clinic appointment. If participants agrees to be in the research, informed consent/assent will be reviewed and signed by all parties. Participant's parent/guardian will be asked to complete a questionnaire. The participant's glucose machine/insulin pump will be downloaded for study purposes. Participant will undergo a fingerstick and a blood draw to collect specific lab values as outlined in the consent.

$35.00

Yes
 

Lina Huerta-Saenz
Erica Miller - at emiller25@pennstatehealth.psu.edu or 717-531-5656
Pediatrics: Endocrinology (HERSHEY)
 

All
Younger than 18 years old
This study is NOT accepting healthy volunteers
STUDY00014114
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Type 1 diabetes diagnosis for more than one year
Age 1-17 years old, any gender
Attendance to the Pediatric diabetes clinic at Penn State Health in Hershey, PA
Most recent hemoglobin A1C below 7.5%

Exclusion Criteria:
Age older than 17 years old
History of seafood allergies and/or milk/dairy related allergies
Medical conditions (such as severe cerebral palsy, etc.) that could make patients unable to communicate with the study team
Existence of other autoimmune diseases in addition to T1D requiring regular treatment with immunosuppressive or anti-inflammatory treatment
Diagnosis of type 2 diabetes, monogenic diabetes (MODY), secondary diabetes, pregnancy, compromised kidney function, or liver diseases
Children's Health, Food & Nutrition, Diabetes & Hormones
I'm interested
Share via email
Show 3 locations

Study Locations

Hide all locations
Location Contacts
Carlisle, PA ,
Harrisburg, PA ,
Hershey, PA ,

A Phase II/III Trial of De-intensified Radiation Therapy for Patients with Early-Stage, P16 Positive Oropharyngeal Cancer (NRG-HN005) (PSCI# 20-011)

The purpose of the first part of this study is to compare the usual treatment of a standard-dose radiation given over 6 weeks with cisplatin chemotherapy to a reduced-dose radiation given over either 6 weeks with cisplatin or 5 weeks with the immunotherapy drug, nivolumab. A lower dose of radiation as compared to the usual radiation treatment dose could be as effective in lengthening the time without your cancer getting worse. Nivolumab with reduced-dose radiation may or may not be as effective in lengthening the time without your cancer getting worse. This study will help the study doctors find out if this different approach is the same or worse than the usual approach.

The purpose of the first part of this study is to compare the usual treatment of a standard-dose radiation given over 6 weeks with cisplatin chemotherapy to a reduced-dose radiation given over either 6 weeks with cisplatin or 5 weeks with the immunotherapy drug, nivolumab. A lower dose of radiation as compared to the usual radiation treatment dose could be as effective in lengthening the time without your cancer getting worse. Nivolumab with reduced-dose radiation may or may not be as effective in lengthening the time without your cancer getting worse. This study will help the study doctors find out if this different approach is the same or worse than the usual approach.

Yes
 

Mitchell Machtay
PSCI-CTO@pennstatehealth.psu.edu 717-531-5471
Medicine: Hematology and Medical Oncology (HERSHEY)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT03952585
SITE00000721
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Pathologically proven diagnosis of squamous cell carcinoma of the oropharynx
Patients must have clinically or radiographically evident measurable disease at the primary site or at nodal stations
P16-positive based on local site immunohistochemical tissue staining
Zubrod Performance Status of 0-1 within 14 days prior to registration
Only English, Spanish, or French speaking patients are eligible to participate as these are the only languages for which the mandatory dysphagia-related patient reported instrument (MDADI) is available

Exclusion Criteria:
Clinical stages T0; T4; T1-2, N0; or any N2 (AJCC, 8th ed)
Recurrent disease
Definitive clinical or radiologic evidence of metastatic disease or adenopathy below the clavicles
Cancers considered to be from an oral cavity site or the nasopharynx, hypopharynx, or larynx, even if p16-positive, or histologies of adenosquamous, verrucous, or spindle cell carcinomas
Carcinoma of the neck of unknown primary site origin (T0 is ineligible, even if p16-positive)
Cancer
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 2 locations

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,
Reading, PA ,

Asymmetric neurodegeneration of central olfactory system in early-stage Parkinson’s disease

This research is being done to study the deterioration of the central olfactory system (sense of smell system) in the brains of patients diagnosed with H&Y stage 1 or 2 Parkinson’s disease compared to that of healthy volunteers.

In this study, you will receive a clinical evaluation and an MRI examination. After that, you will be followed every 12 months for up to 4 years.

up to a total of $250.00.

Yes
 

Jian-Li Wang
Jianli Wang - at jwang2@pennstatehealth.psu.edu or 717-531-0003, ext=323023
Radiology (HERSHEY)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00005378
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Cognitively-normal H&Y stage 1 PD patients. A physician-documented parkinsonian symptom onset between the ages of 40-59. 1st visit prior to age 68. PD stage I diagnosis must be documented for a min of 2 years.
Cognitively-normal H&Y stage 2 PD patients. H&Y stage 2, as defined by an exam in the practically defined “off” state, and have a diagnosis of PD at the age of 59 or younger. 1st visit prior to age 68
Healthy participants between ages 40-67 at their first visit.
Able and willing to provide informed consent
Fluent in written and spoken English

Exclusion Criteria:
Parkinson-plus syndrome
Dementia
Previous antipsychotic or anti-dopamine drug therapy
Traumatic head injury
Other neurological diseases or disorders
Neurology
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Effects of acid sensing ion channels blockade with amiloride on exercise pressor reflex in patients with peripheral artery disease

The purpose of the study is to determine the effects of amiloride on the blood pressure response during exercise, and exercise tolerance in patients with PAD and healthy controls.

There will be 3 in-person visits. You will take a capsule of amiloride or placebo before visits 2 and 3 and blood pressure, heart rate and other physiological measurements will be recorded.

You will receive $25 per hour for your participation in this research study

Yes
 

Jian Cui
Cheryl Blaha - at cblaha@pennstatehealth.psu.edu or 717-531-1605
Heart and Vascular Institute (HERSHEY)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00018295
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Men and women age 21- 85 years
Any race or ethnicity
Healthy: Free of acute medical conditions
PAD: Diagnosis of PAD, no pain at rest

Exclusion Criteria:
Pregnant or nursing women
Resting blood pressure of 150/100 or higher
Already taking amiloride
Recent heart attack or epilepsy
Peripheral neuropathy
Men's Health, Heart & Vascular, Women's Health
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

GLNE 007 Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

The purpose of this study is to see if stool or blood can be used to determine whether or not a patient has any colon polyps or colon cancer. This study will compare these biological samples (blood, urine, stool) to any colonoscopy or surgery a patient has to see if the outcome could be predicted.

No
 

Mack Ruffin
Amanda Taylor Gehman - at ataylor6@pennstatehealth.psu.edu or 717-531-1283
Family and Community Medicine (HERSHEY)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
NCT00843375
STUDY00011627
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Adult 18+
Subjects with Colon Cancer or Adenoma
OR subjects undergoing colonoscopy screening

Exclusion Criteria:
Inflammatory Bowel Disease
HIV/Hepatitis
Have had or are receiving chemotherapy or radiation
Have had surgery for your colon cancer
Cognitive Impairment
Prevention, Cancer
I'm interested
Share via email
See this study on ClinicalTrials.gov

Sound Symbolism and Aphasia

Sound symbolism is the idea that the sound of a word alone can convey its meaning. Aphasia is a language impairment, occurring most often as a result of a stroke. There is some evidence that sound-symbolic language is preserved in stroke patients. Studies in this protocol will investigate the extent to which this is so, and whether sound-symbolic language could be a rehabilitation strategy for aphasia.

We will ask you to listen to real words and non-words and make judgements about them. We may also ask you to complete some tests of language ability. The total time commitment may be up to four hours but will be split into two sessions.

Amount varies depending on the study

Yes
 

Krishnankutty Sathian
Josh Dorsi - at jdorsi@pennstatehealth.psu.edu
Neuroscience and Experimental Therapeutics (HERSHEY)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00022919
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Must be aged 18 or older
Must have English as your first language
Must have normal or corrected-to-normal vision
Must report normal hearing
May have a recent diagnosis of aphasia following a stroke

Exclusion Criteria:
Self-reported hearing difficulty
Bilingual persons may be excluded from some studies
Minors under the age of 18
Language & Linguistics
Not applicable
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Identifying and Predicting Inflection Points in Human-Agent Action Teams Using Relational Event Modeling

The purpose of this study is to better understand how human teams with non-human virtual agent team members operate and function.

If you agree to be in this study, you will be fitted to sensors that will measure your neurophysiological (i.e., brain, cardiac, and respiratory) signals while you complete group tasks in person or in virtual reality. This interaction will be recorded and coded. You will also be asked to complete several questionnaires about your demographics, behaviors, and emotions.

$38

Yes
 

Nina Lauharatanahirun
Nina Lauharatanahirun - at nina.lauhara@psu.edu or 814-865-4319
Biomedical Engineering (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00022340
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
18 years or older
English-speaking
Willing/able to travel to Penn State University Park location research site
No cardiovascular, metabolic, or neurological condition
Willing to wear EEG sensors

Exclusion Criteria:
History of concussion
Report or diagnosis of a neurological injury or disorders related to cardiovascular-respiratory, metabolic or brain function
Cannot speak or read English
Unable to provide informed consent
Not willing to wear EEG sensors
Education
Not applicable
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

Characterizing Physical Interactions Used to Correct Robot Errors for Learning from Demonstration

The purpose of this research study is to learn about how humans provide corrections to robot movements when the robot makes mistakes while performing a task. Understanding the intent of humans can inform how we incorporate the information provided by that interaction into machine learning algorithms that improve the robot’s task performance in future.

Participants will observe the robot performing three different tasks. The robot will place a peg in a hole, pickup and pour a cup, and draw and erase an image on a whiteboard. The robot may or may not make mistakes while performing these tasks. Mistakes may be minor or may be significant such as colliding with an object or the work table. Participants will be asked to correct the robot’s mistake by moving the robot arm or stopping the task execution altogether by hitting a red stop button. After observing the robot perform each task several times, you will be asked to demonstrate a new task to the robot. The robot will then try to replicate your demonstration and you may choose to provide corrections to improve the robot’s execution of the task anytime you think it is making a mistake or not performing well enough.

20

Yes
 

Katie Fitzsimons
Junru Pang - at jvp6149@psu.edu
Mechanical and Nuclear Engineering (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00022768
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Ages 18-65

Exclusion Criteria:
Under 18
Upper limb injuries
Not applicable
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

Understanding Practices on Social Network Sites and Social Relationships

Social network site (SNS) use has been very integrated into our daily practices. The distinctions between offline and online social relationship management become blurred with the mediation of SNSs. We are interested in how people perceive and use SNS and engage in social relationship management, such as self-disclosure or privacy management. Users may appropriate technological features to meet their own needs and such practices may be different from how others use the sites. The discrepancy of usage may in turn influence social relationship maintenance.

Yes
 

Tina Yuan
Tina Yuan - at tuy11@psu.edu
Information Sciences and Technology (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00007574
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Social network site user (Facebook, Instagram, WeChat, etc.)
18 years and older

Exclusion Criteria:
Non-social network site users
Below 18 years old
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

Executive Functioning in Young Adults

This study is designed to better understand how people complete complicated tasks, and the best ways in which to measure their performance. If you agree to the study, you will be asked to fill out questionnaires on your thoughts, feelings, and behaviors; take a short interview on the same; and complete brain teasers and computerized tests of attention and learning.

There are several steps to determining whether you are a good fit for the study. If you agree to be in the study, then we will send you a link to complete online questionnaires (~10 min) on your thoughts, feelings, and behaviors. If you are a good fit, then we will schedule a laboratory visit in Moore Building at the University Park campus (maximum length of time = 3 hours). During that visit you will complete an interview and more questionnaires, brain teasers, and computerized tests of attention and learning. The visit will be video recorded for quality assurance.

$50

Yes
 

Cynthia Huang-Pollock
Cynthia Huang-Pollock - at ChildAttention@psu.edu or 814-863-0250
Psychology (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00024257
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Age 18-30
Speak English as first language, or are fluent in English
Participants must meet study guidelines based on screening process

Exclusion Criteria:
Major health, medical, or neurologic conditions that prevent full participation
If taking a stimulant medication (e.g. Ritalin), must be willing to discontinue its use for a period of 24-48 hours prior to the lab visit
Education, Mental & Behavioral Health
Not applicable
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

Research on Survivorship Experiences: Disparities in cancer-related outcomes between rural and non-rural cancer survivors in the catchment areas of the Big 10 Cancer Research Consortium's Population Science Working Group

The objective of this cross sectional survey study is to describe the social and psychological outcomes of cancer survivors and characterize the disparities between rural and non-rural cancer survivors. We will collaborate will members of the Big 10 Cancer Research Consortium's Population Science Working Group to invite cancer survivors in rural and non-rural communities to complete one online survey, with each site targeting cancer survivors in their catchment areas. At Penn State, we will target recruitment to cancer survivors living in Pennsylvania. We plan to enroll 150 participants. It will take participants 30-40 minutes to complete the study and they will receive a $15 Amazon gift card for their time and effort.

Study participants will be asked to complete one online survey about their experience as a cancer survivor. A member of the Penn State study team will call the participant to confirm eligibility before sending a $15 Amazon e-gift card. The entire study should take between 30-40 minutes to complete.

$15

No
 

Jennifer Moss
Leonard Kishel - at Casper@pennstatehealth.psu.edu or 717-531-0003, ext=321657
Family and Community Medicine (HERSHEY)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
NCT00000000
STUDY00025475
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
diagnosis of primary pathologic breast, colorectal, lung, melanoma, prostate, uterine, endometrial, or blood cancers (leukemia, lymphomas)
non-metastatic cancer
1-5 years post completion of active treatment
no current evidence of cancer
living in certain counties in south central Pennsylvania

Exclusion Criteria:
no internet access
cannot speak or read English
unable to provide informed consent
less than 18 years old at time of cancer diagnosis
Cancer
Not applicable
I'm interested
Share via email
See this study on ClinicalTrials.gov

BCC016: DFMO for Medullo

This is a study of the drug DFMO (difluoromethylornithine) for medulloblastoma that has returned or not responded to treatment. DFMO is an oral drug that inhibits a certain enzyme (protein) in blood which is associated with a bad outcome in neuroblastoma cases. Cancer cells have pathways that drive the cancer to grow and DFMO targets the specific pathway of this enzyme to turn these cells off.

You will have exams, tests, and procedures while on the study to evaluate whether you can participate in the study and how you are doing while on the study. These include physical exams, blood tests, urine tests, bone marrow aspirate and biopsies, heart tests, hearing tests, and imaging evaluations such as MRI of your brain and spine. You will receive treatment on this study for a total of about 2 years. After treatment, you will have follow-up examinations and medical tests. We would like to continue to find out about your health for about 5 years after you complete the study.

Yes
 

Valerie Brown
Suzanne Treadway - at streadway@pennstatehealth.psu.edu or 717-531-3097
Pediatrics: Hematology/Oncology (HERSHEY)
 

All
All
This study is NOT accepting healthy volunteers
NCT04696029
SITE00000984
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
You have had medulloblastoma that was either high risk or had relapsed or had not responded to therapy
You are 21 years old or younger
You must have no evidence of disease at this time

Exclusion Criteria:
You are currently taking another study drug or an anticancer drug
Cancer
Prefer not to display
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Vivistim Registry for Paired VNS Therapy (GRASP)

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post- stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process.

The purpose of this study is to follow individuals that plan to be implanted with the MicroTransponder Vivistim® System. We will be collecting data at various time points over 3 years. Data collection includes questionnaires about arm movement, quality of life, productivity, and use of healthcare services. This study lasts for 3 years, with 6 total visits. One visit is prior to being implanted and 5 are post-implant. Visits can be done via telephone or in person. Questionnaires and Therapy data will be collected at each visit.

$600.00

Yes
 

Raymond Reichwein
Kasey Schutt - at klong10@pennstatehealth.psu.edu or 717-531-0003, ext=289869
Neurology (HERSHEY)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT05301140
STUDY00022244
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
18 years of age or older
You have suffered a stroke
You have moderate to severe upper limb deficits
You plan to be implanted with the MicroTransponder Vivistim® System.

Exclusion Criteria:
You have not had a stroke
You do not have upper limb deficits.
You are currently enrolled in an investigational study.
You have previously been implanted with a Vivistim® System.
Neurology
Survey(s)
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Neural Correlates of Cognitive Dysfunction in Postural Tachycardia Syndrome

Postural tachycardia syndrome (POTS) is a chronic syndrome in which the heart beats too quickly when standing. POTS primarily affects young women. People with POTS also experience symptoms such as feeling faint, fatigue, nausea, and mental clouding or "brain fog." “Brain fog” is one of the most bothersome symptoms of POTS and it is unknown why people with POTS experience this symptom. Some studies have shown that POTS patients have problems with attention, memory and executive function (ability to plan, organize information, and adapt to changes) while seated and when upright. In this study, we will evaluate how brain function during mental tasks is affected in people with POTS compared to healthy volunteers. All volunteers will complete mental tasks while lying down and standing. If eligible, we will measure brain activity using functional magnetic resonance imaging (fMRI).The findings from this study will increase our understanding of the mental complaints in people with POTS, to hopefully help with development of new treatments.

There will be three in person visits for this study. At the screening visit, participants will undergo a detailed medical history and physical examination and then will complete a mental test while lying down and standing. If eligible based on the results of the mental test, participants will undergo a pregnancy test if female and of childbearing potential, measurements of blood pressure and heart rate and blood draws while lying down and standing up, and a test to determine if they can tolerate being in a lower body negative pressure (LBNP) device that distributes more blood to the legs to mimic standing. If eligible based on the results of the screening visit, participants will be asked to complete an online questionnaire and two study visits that are separated by at least one week. At these study visits, they will perform a mental test in a magnetic resonance imaging (MRI) scanner. The LBNP device will also be used while in the MRI scanner to distribute more blood to the legs to mimic standing.

$25 per hour; additional $25 for completion of online questionnaire

Yes
 

Amy Arnold
Aimee Cauffman - at acauffman@pennstatehealth.psu.edu or 717-531-1617
Neuroscience and Experimental Therapeutics (HERSHEY)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
NCT04137757
STUDY00012860
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Men and women of all races
18- 60 years old
Previously Diagnosed with POTS or healthy people without chronic illness
Capable of giving informed consent

Exclusion Criteria:
Age <18 years or >60 years
Pregnant or breastfeeding women
Other potential causes for tachycardia (e.g. prolonged bed rest, dehydration)
Taking stimulant medications within the past 3 months as these may alter cognition
Unable to tolerate an MRI scanner (e.g. claustrophobia, implanted metal)
Heart & Vascular, Neurology
Not applicable
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Neurobehavioral Effects of Frequent Co-use of Alcohol and Cannabis

This study will examine neural reactivity to stress in young adults who use alcohol and cannabis and link these responses to behaviors in everyday life.

You will be asked to complete the following: 1) An in-lab intake appointment for interviews and questionnaires, and a smartphone-based training session 2) A 14-day burst of smartphone-based reporting in daily life 3) An in-lab neuroimaging training session and scan, and bloods draws 4) Two additional 14-day bursts (total of 28 days) of smartphone-based reporting in daily life, one at 6 months post-MRI and one at 12 months post-MRI 5) 6-month follow-up appointment for interviews and questionnaires 6) 12-month follow-up appointment for interviews and questionnaires

717

Yes
 

Eric Claus
Skylar Lin - at fiercestudy@psu.edu or 814-844-2733
Biobehavioral Health (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00023420
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
18-30 years old
Use an android or apple smartphone
Cannabis use
Alcohol use
Willing to do MRI scan

Exclusion Criteria:
Women who are pregnant or lactating
Inability to give informed consent
Any contraindications for MRI (e.g., medical devices in the body, claustrophobia, etc.)
Mental & Behavioral Health
Not applicable
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

brain-computer interface in the epilepsy monitoring unit

Patients who are undergoing monitoring with scalp or intracortical EEG can be followed in the epilepsy monitoring unit for more than a week. This clinical resource provides an opportunity to conduct a comparison of imagery-based brain-computer interface control between scalp and intracranial recordings. The outcomes will be the information density of the signal of intent using the two recording methods, as well as the accuracy in controlling a single- and multi-dimensional computer task. A control group of neurologically-healthy control participants will be compared.

There will be two in-person visits lasting one hour each. Participants will complete a set of questionnaires and have an electroencephalography (EEG) recording performed while completing computer tasks.

$40

Yes
 

Andrew Geronimo
Andrew Geronimo - at ageronimo@pennstatehealth.psu.edu or 717-531-0003, ext=282576
Neurosurgery (HERSHEY)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00009104
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Age and gender matched to the patient cohort
No history of neurological disorders
Age 18 years or older

Exclusion Criteria:
Those unable to undergo electroencephalography (EEG) due to either allergies to lotions, cuts on the scalp or active infections.
Non-English Speakers. The questionnaires and instructions for imagery are available in English only.
Neurology
Not applicable
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Invisible Sojourners: Second Language Socialization Among International Spouses

This study will examine how international spouses improve their English ability and form connections with the local community. Participants will be interviewed to learn about their experiences. Social events that are found to be positive will be recorded so that the interactions in that space can be analyzed to determine how they help international spouses.

Yes
 

Jade Sandbulte
Jade Sandbulte - at jfs5644@psu.edu
Applied Linguistics (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00009835
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Traveled to the U.S. with a spouse who was enrolled at Penn State
Understands spoken English

Exclusion Criteria:
Is not a student at Penn State OR was not a student when you first arrived
Education, Language & Linguistics
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

Caregiver's Perceptions of High-quality Early Education and Care

This is an exploratory study which looks at how caregivers define high-quality early education and care. Participants will fill out a questionnaire containing open-ended and closed-ended questions. It will take participants no longer than 20 minutes to complete.

No
 

Hannah Mudrick
Hannah Mudrick - at hxm99@psu.edu
Behavioral Sciences and Education (HARRISBURG)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00011162
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Adults age 18 and older
Adults who are fluent in English
Adults who are regular caregivers of children between birth and age 5
Individuals who can read and respond to written close- and open-ended survey questions electronically
Individuals who live in the United States

Exclusion Criteria:
Individuals under the age of 18
Individuals who are not fluent in English
Individuals who are not regular caregivers of children between birth and age 5
Individuals with poor reading comprehension and are otherwise limited in their ability to read and respond to survey questions
Individuals who do not currently live in the United States of America
Children's Health, Education, Mental & Behavioral Health
I'm interested
Share via email

NSF Proposal 2000047: Understanding the contribution of individual differences to domain-general and domain-specific components of false memories in both young and older adults

This research study investigates the neural processes underlying how people process, store, and remember visual or auditory information.

Participants ages 18-30 will participate for one 2-hour session involving 1 hour inside the MRI scanner. Participants ages 60-85 will participate for five sessions total, two of them being MRI scans. All five sessions will occur between 7-10 days of each other and scheduling is very flexible.

$15.00/hour for behavioral tasks, $20.00/hour for fMRI scanner tasks.

Yes
 

Nancy Dennis
Luke Dubec - at lxd5406@psu.edu
Psychology (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00010893
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Ages 18-30
Ages 60-85
High school education

Exclusion Criteria:
Colorblindness
Learning disability
Stroke, TIA, or severe brain injury
Unsafe metal implanted in body
Neurology, Mental & Behavioral Health
Not applicable
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

The Influences of Performance Expectancy on Cryptocurrency Traders’ Behavior in Initial Coin Offering (ICO) Projects

The study's primary objective is to see how people react to the influences of performance expectancy in Initial Coin Offering (ICO) projects. As a participant in this study, you will be asked to answer 28 questions about your experiences with ICO projects. Then, at the end of the survey, participants will be briefed on the potential correlations between performance expectancy and how this phenomenon influences participants' behaviors toward ICO projects.

The participant will be asked to complete a questionnaire composed of 28 questions about ICO projects during the study. Then, at the end of the survey, participants will be debriefed on the potential correlations between performance expectancy and ICO projects.

No
 

Oscar Orellana
ojo5076@psu.edu
World Campus (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
STUDY00020482
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Participants with a public wallet address.
Active cryptocurrency traders.
18 years of age or more
Residing in The US

Exclusion Criteria:
Participants without a public wallet address
Non active cryptocurrency traders
Less than 18 years of age
Not residing in the US
Mental & Behavioral Health
I'm interested
Share via email

The Role of Emojis in Generating and Responding to Critiques of Work

An online survey about emojis for text feedback on a short story or design. You categorize emojis for this task, write a critique with emojis, and then answer a survey for an Amazon gift card.

No
 

Chulakorn Aritajati
Chulakorn Aritajati - at cya5092@psu.edu
Information Sciences and Technology (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
STUDY00011180
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
18 year old or older
Can read and write English

Exclusion Criteria:
Under 18 years
Education, Language & Linguistics
I'm interested
Share via email

PSCI 24-041 Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence—A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)

This trial will compare the use of elacestrant versus standard endocrine therapy in those who are node positive, ER +, Her2 - with high risk of the cancer coming back

Participants will be expected to come to all visits, take all study medication as instructed by the study doctor, report any new medications, prescription or over the counter, report all side effects.

Yes
 

Cristina Truica
PSCI-CTO@pennstatehealth.psu.edu 717-531-5471
Medicine: Hematology and Medical Oncology (HERSHEY)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT06492616
STUDY00025850
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Adult women or men aged ≥18 years old, or older if required by local regulations, at the time of informed consent signature.
Histopathologically or cytologically confirmed ER-positive (≥ 10% by immunohistochemistry [IHC]), HER2-negative [IHC = 0 or 1, or (IHC = 2 and ISH-negative)]
Participants considered at high risk of recurrence
Participants who have received at least 24 months but not more than 60 months of endocrine therapy
Participants are to be between 2 to 6 years from the date of curative surgical resection

Exclusion Criteria:
Participants with inflammatory breast cancer.
Participants with stage IV metastatic breast cancer.
History of any prior (ipsilateral and/or contralateral) invasive breast cancer
Major surgery within 4 weeks of starting study therapy
Cancer
Experimental drug compared to an approved drug
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Understanding the Relationship Between Discrimination and Sickle Cell Pain

This is a survey and interview study recruiting patients with sickle cell disease (SCD). Participants will answer questionnaires and complete a remote interview about health care experiences, pain, and discrimination. Natural language processing of interview transcripts will be used to quantify linguistic features indicative of subjective associations between individual experiences of racial discrimination and sickle cell pain.

Participants will be asked to fill out questionnaires and answer questions during an interview.

$50

No
 

Elizabeth Losin
Jacob Gronemeyer - at jgronemeyer@psu.edu
Biobehavioral Health (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
STUDY00023905
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
A diagnosis of Sickle Cell Disease
18 years or older

Exclusion Criteria:
Under the age of 18
Does not have a confirmed diagnosis of Sickle Cell Disease
Unable or unwilling to participate in the interview or to be recorded
Not Fluent in the English langauge
Blood Disorders, Pain Management
Not applicable
I'm interested
Share via email

Mechanisms of Cardiovascular Disease (MCD)

The primary objective of this protocol, Mechanisms of Cardiovascular Disease (MCD) is to collect biological specimens and data from patients with cardiovascular disease (CVD) to study the mechanisms that contribute to cardiovascular dysfunction and disease.

If you decide to participate in this study, you will be asked to provide a blood sample and possibly additional optional samples, either immediately or later. Additional samples may include saliva, cheek swab, urine, waste tissue or nasal swabs. You will decide whether you are willing to provide these other samples. Clinical data will be included in the dataset along with your sample.

Yes
 

Elisa Bradley
PSHVICTO@pennstatehealth.psu.edu 717-531-5967
Heart and Vascular Institute (HERSHEY)
 

All
All
This study is also accepting healthy volunteers
STUDY00019928
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
adults 18 years or older with or without cardiovascular disease
children less than 18 years with or without cardiovascular disease

Exclusion Criteria:
Prisoners are excluded from participation
Adult participants who are unable to provide a biologic sample
Heart & Vascular
Not applicable
I'm interested
Share via email
Show 6 locations

Study Locations

Hide all locations
Location Contacts
Harrisburg, PA ,
Hershey, PA ,
Reading, PA ,
State College, PA ,
Wilkes-Barre/Scranton Area, PA ,
York, PA ,

Examining executive functioning deficits, affective deficits, and social functioning to better understand disruptive behaviors and callous-unemotional traits

This research seeks to better understand functioning in children who differ in symptoms of Attention-Deficit Hyperactivity Disorder (ADHD), conduct problems (CP), and callous-unemotional (CU) traits, ages 6 - 13. Specifically, this research is being done to find out how these different types of behaviors impact cognitive skills (like attention, impulsivity, working memory, emotion identification) and social functioning to help inform future treatment with these children.

Yes
 

Dan Waschbusch
Delshad Shroff - at abc@pennstatehealth.psu.edu or 717-531-0003, ext=285968
Psychiatry and Behavioral Health (HERSHEY)
 

All
Younger than 18 years old
This study is also accepting healthy volunteers
STUDY00005703
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Children ages 6 to 13 years old
Estimated IQ of 80 or above
Willing and able to discontinue psychoactive medication treatment for the experiemental session, if relevant
Caregiver and child must be fluent in written and spoken English

Exclusion Criteria:
Current or past diagnosis of intellectual disability, any psychotic disorder or autism spectrum disorder, or schizophrenia or rleated disorders
Psychiatric symptoms requiring urgent treatment, such as mania or suicidal ideation/homicidal ideation
Unable to be tested off medication
Physical disabilities that are incompatible with completing laboratory tasks such as hearing or speech impairments, or visual impairments that cannot be corrected with visual aids
Mental & Behavioral Health
I'm interested
Share via email
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,

Challenging Veteran Stereotypes: An Investigation Around Veteran Status and Its Influence on Aggression, Ostracism, Stress, and Counterproductive Work Behaviors

The purpose of this study is to better understand how civilian stereotypes about veterans impact veterans' feelings about themselves and others, and how that influences veteran behavior in the workplace.

No
 

Bruce Tirrell
Bruce Tirrell - at bkt5174@psu.edu or 201-787-6073
Labor and Employment Relations (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
STUDY00019166
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Current undergraduate or graduate students at PSU
Age 18 or older

Exclusion Criteria:
Not a PSU Student
Under age 18
Mental & Behavioral Health
I'm interested
Share via email

Storytelling on Snapchat

This study will examine via ethnographic observation the Story feature on social media. Participants will be asked to provide their Snapchat or Instagram username and must be willing to let the researcher observe the Stories that they post. The primary aims are to illuminate how and why people are using the Story feature on social media, and to analyze how this feature is changing how we relate to and understand the world around us.

No
 

Michael Krieger
Michael Krieger - at mlk75@psu.edu or 646-430-0117
Mass Communications (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is NOT accepting healthy volunteers
STUDY00011907
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
User of the Story feature on Snapchat or Instagram
At least 18 years old

Exclusion Criteria:
Anyone under the age of 18 years old
Non users of social media
Education, Mental & Behavioral Health, Language & Linguistics
I'm interested
Share via email

Transient Receptor Potential Channels in Human Skin

Menthol, capsaicin, and camphor are active ingredients often found in over-the-counter pain relief creams and gels. These ingredients typically work by interacting with certain receptors in the skin that are sensitive to temperature changes. There is limited information on how combining menthol with other substances that target similar receptors affects the body. These naturally occurring substances found in plants can widen small blood vessels in the skin through specific processes controlled by nerves in the skin. This study aims to understand how menthol, camphor, and capsaicin individually and together affect sensory function and blood flow in the skin. Additionally, as people age, their skin's nerve and blood vessel function tends to decrease. The study also seeks to explore how aging impacts the effects of these substances on sensory perception and how nerves and blood vessels work together in the skin.

There will be a screening visit and then 6 experiment visits where different topical analgesics will be applied to the forearm skin. We will measure skin blood flow.

240

Yes
 

Lacy Alexander
Susan Slimak - at sks31@psu.edu
Kinesiology (UNIVERSITY PARK)
 

All
18 year(s) or older
This study is also accepting healthy volunteers
NCT06444594
STUDY00024921
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
healthy adults

Exclusion Criteria:
diabetes
tobacco use
sensitivity to menthol, camphor or capsiacin
pregnancy
breastfeeding
Heart & Vascular, Pain Management
Prefer not to display
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,

Feasibility of an experimental protocol for studying the effects of changes in bedtime on eating behavior in children

The purpose of this study is to find out if parents and children 6-10 years old are willing and able to follow a protocol to be used to study the effects of short and/or variable sleep in children. During each of three, one-week long periods, we are asking parents to follow one of the following bedtime schedules: 1) habitual bedtime; 2) 1 hour later bedtime; or 3) variable bedtime (+/- 1 hour of habitual bedtime each day). Children will wear a sleep tracker and parents will complete daily diaries. We will also ask participants questions about their experiences completing the protocol.

Participants will attend an enrollment visit at the Noll Laboratory at Penn State's campus where we will go over the study and give participants a sleep monitor. We will then ask parents to put their child to bed at different, specified times over the course of three weeks - normal bedtime in one week; 1 hour later than their usual bedtime in another week; and at a different assigned time each day that will be +/- 1 hour of their normal bedtime during the third week. During all three weeks, children will wear a sleep monitor on their wrist (similar to a Fitbit), and parents will answer a short survey each evening on their smartphone or other device. At the end of the study, participants will attend a final visit (either in-person or by Zoom depending on preference) to answer questions about their experience with the protocol.

$150

Yes
 

Emily Hohman
Emily Hohman - at eeh12@psu.edu or 814-865-5245
Child Health Research Center (UNIVERSITY PARK)
 

All
All
This study is also accepting healthy volunteers
NCT06501690
STUDY00025204
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Child 6-10 years
Parent 18+ years
Child has a regular bedtime

Exclusion Criteria:
Child medical conditions affecting sleep or development
Child regular use of supplements or medications for sleep (e.g. melatonin, antihistamines)
Children's Health, Sleep Management
Not applicable
I'm interested
Share via email
See this study on ClinicalTrials.gov
Show 1 location

Study Locations

Hide all locations
Location Contacts
State College, PA ,